Laila el Jarari

Bortezomib Induction and Maintenance Treatment in Patients With Newly Diagnosed Multiple Myeloma: Results of the Randomized Phase III HOVON-65/ GMMG-HD4 Trial

Pieter Sonneveld, Ingo Schmidt‐Wolf, Bronno van der Holt et al. · Journal of Clinical Oncology · 2012 · 826 citations · Full text

Medicine, Hematology, Pharmacotherapy +16

Gene expression profiling for molecular classification of multiple myeloma in newly diagnosed patients

Annemiek Broyl, Dirk Hose, Henk M. Lokhorst et al. · Blood · 2010 · 338 citations · Full text

Life Sciences, Molecular Biology, Oncology +16

A gene expression signature for high-risk multiple myeloma

Rowan Kuiper, Annemiek Broyl, Yvonne de Knegt et al. · Leukemia · 2012 · 303 citations

Medicine, Molecular Biology, Oncology +14

Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65/GMMG-HD4 trial

Annemiek Broyl, Sophie L. Corthals, Joost L.M. Jongen et al. · The Lancet Oncology · 2010 · 220 citations

Medicine, Neurology, Oncology +14

High cereblon expression is associated with better survival in patients with newly diagnosed multiple myeloma treated with thalidomide maintenance

Annemiek Broyl, Rowan Kuiper, Mark van Duin et al. · Blood · 2012 · 129 citations · Full text

Medicine, Hematology, Oncology +9